Sana Biotechnology, Inc. (SANA)
5.025
+0.08
(+1.72%)
USD |
NASDAQ |
Dec 11, 15:16
Sana Biotechnology Total Liabilities (Quarterly): 240.12M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Illumina, Inc. | 3.796B |
| Pacific Biosciences of California, Inc. | 767.07M |
| Editas Medicine, Inc. | 188.30M |
| Intellia Therapeutics, Inc. | 176.85M |
| CEL-SCI Corp. | 13.31M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 435.43M |
| Shareholders Equity (Quarterly) | 195.31M |
| Debt to Equity Ratio | 0.4211 |
| Current Ratio | 4.555 |
| Net Debt Paydown Yield | 0.35% |